Paper38788198
Dysfunction of type 1 and type 2 immune cells: a lesson from exhausted-like ILC2s and their activation-induced cell death.
Ebihara T and 6 others. Int Immunol, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Dysfunction of type 1 and type 2 immune cells: a lesson from exhausted-like ILC2s and their activation-induced cell death. Papers, record 38788198. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38788198
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dysfunction of type 1 and type 2 immune cells: a lesson from exhausted-like ILC2s and their activation-induced cell death.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunity, Innate | Major topic |
| Animals | |
| Humans | |
| Cell Death | |
| Th2 Cells | |
| Lymphocytes | |
| Lymphocyte Activation | |
| Th1 Cells | |
| Hypersensitivity |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 21H02707 | Japanese Society for the Promotion of Science | PubMed | ||
| Takeda Science Foundation | PubMed | |||
| Yasuda Memorial Medical Foundation | PubMed | |||
| Koyanagi Foundation | PubMed |
Source PubMed
References88
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31810882 | Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection. | Immunity | 2019 | https://conductscience.org/library/papers/31810882 | PubMed |
| 2 | 30294963 | The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms. | Immunol Rev | 2018 | https://conductscience.org/library/papers/30294963 | PubMed |
| 3 | 27749840 | A tissue checkpoint regulates type 2 immunity. | Nat Immunol | 2016 | https://conductscience.org/library/papers/27749840 | PubMed |
| 4 | 28804130 | Innate lymphoid cells: major players in inflammatory diseases. | Nat Rev Immunol | 2017 | https://conductscience.org/library/papers/28804130 | PubMed |
| 5 | 22544698 | Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells. | Blood | 2012 | https://conductscience.org/library/papers/22544698 | PubMed |
| 6 | 24530057 | Molecular and transcriptional basis of CD4⁺ T cell dysfunction during chronic infection. | Immunity | 2014 | https://conductscience.org/library/papers/24530057 | PubMed |
| 7 | 20929731 | Lineage relationship analysis of RORgammat+ innate lymphoid cells. | Science | 2010 | https://conductscience.org/library/papers/20929731 | PubMed |
| 8 | 29427641 | GITR cosignal in ILC2s controls allergic lung inflammation. | J Allergy Clin Immunol | 2018 | https://conductscience.org/library/papers/29427641 | PubMed |
| 9 | 31207604 | TOX is a critical regulator of tumour-specific T cell differentiation. | Nature | 2019 | https://conductscience.org/library/papers/31207604 | PubMed |
| 10 | 19258704 | Th2 cell hyporesponsiveness during chronic murine schistosomiasis is cell intrinsic and linked to GRAIL expression. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19258704 | PubMed |
| 11 | 30638736 | The Emergence and Functional Fitness of Memory CD4+ T Cells Require the Transcription Factor Thpok. | Immunity | 2019 | https://conductscience.org/library/papers/30638736 | PubMed |
| 12 | 25023623 | Distinctive features of CD4+ T cell dysfunction in chronic viral infections. | Curr Opin HIV AIDS | 2014 | https://conductscience.org/library/papers/25023623 | PubMed |
| 13 | 28490441 | PD-1 regulates KLRG1+ group 2 innate lymphoid cells. | J Exp Med | 2017 | https://conductscience.org/library/papers/28490441 | PubMed |
| 14 | 20200518 | Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. | Nature | 2010 | https://conductscience.org/library/papers/20200518 | PubMed |
| 15 | 19664943 | A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. | Immunity | 2009 | https://conductscience.org/library/papers/19664943 | PubMed |
| 16 | 22981535 | Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. | Immunity | 2012 | https://conductscience.org/library/papers/22981535 | PubMed |
| 17 | 29196657 | Alternative activation generates IL-10 producing type 2 innate lymphoid cells. | Nat Commun | 2017 | https://conductscience.org/library/papers/29196657 | PubMed |
| 18 | 32117816 | Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/32117816 | PubMed |
| 19 | 25617223 | Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. | J Allergy Clin Immunol | 2015 | https://conductscience.org/library/papers/25617223 | PubMed |
| 20 | 30944315 | NKG2A is a NK cell exhaustion checkpoint for HCV persistence. | Nat Commun | 2019 | https://conductscience.org/library/papers/30944315 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41787604 | PD-1 genetic fate mapping uncovers immune cell diversity mediating the efficacy of combined PD-1 blockade and chemotherapy. | Oncoimmunology | 2026 | https://conductscience.org/library/papers/41787604 | PubMed |
| 41363790 | Compartment-Specific NK Cell Phenotypes Reveal Distinct Maturation and Activation States in Inflammatory Arthritis. | J Innate Immun | 2025 | https://conductscience.org/library/papers/41363790 | PubMed |
| 40877162 | Infective Endocarditis and Valve Surgery in a Systemic Lupus Erythematosus Patient Following Splenectomy: A Case Report with Immunological Analysis. | In Vivo | 2025 | https://conductscience.org/library/papers/40877162 | PubMed |
| 40795986 | Mathematical modelling of macrophage and natural killer cell immune response during early stages of peritoneal endometriosis lesion onset. | J R Soc Interface | 2025 | https://conductscience.org/library/papers/40795986 | PubMed |
| 40433639 | Immunomodulation by helminthic parasites and worm therapy. | Trop Parasitol | 2025 | https://conductscience.org/library/papers/40433639 | PubMed |
| 39932617 | Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders. | Clin Rev Allergy Immunol | 2025 | https://conductscience.org/library/papers/39932617 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38788198
GET https://conductscience.org/api/papers/v1/38788198/references?page=2